Skip to main content
Premium Trial:

Request an Annual Quote

Genomics One Reports Lower Revenues, Higher Net Loss for 2004

NEW YORK, Feb. 21 (GenomeWeb News) - Genomics One reported last week an increased net loss in 2004 amid declining revenues.

According to the Quebec-based genomics products research firm, its sales for the year were down 11.7 percent to $328,426 from 2003. Genomics One attributed the drop to the weakening US dollar, which allowed American competitors to sell their products in Canada at reduced prices. As a result, Genomics One said it had to reduce the prices on its products to remain competitive.

Costs associated with commercialization and market development rose to $635,211 in 2004 from $535,349 the year before. Meanwhile, general and administrative expenses in 2004 dropped to $878,636 from about $1 million in 2003.

Genomics One posted a net loss of $798,932 in 2004, up from a loss of $589,972 in 2003.

The company had working capital of $871,463 at the end of 2004, and said that it seeking additional financing to ensure that it has resources to fund operations beyond 2005.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.